Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia

The phase 3 ALFA-0701 trial demonstrated improved outcomes with fractionated-dose gemtuzumab ozogamicin (GO) combined with standard chemotherapy vs. standard chemotherapy alone in adults with de novo acute myeloid leukemia (AML). We examined post-transplant outcomes and occurrence of hepatic veno-oc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: Pautas, Cécile, Raffoux, Emmanuel, Lambert, Juliette, Legrand, Ollivier, Chantepie, Sylvain, Gastaud, Lauris, Marolleau, Jean-Pierre, Thomas, Xavier, Turlure, Pascal, Benner, Rebecca J., Vandendries, Erik, Gogat, Karïn, Dombret, Hervé, Castaigne, Sylvie
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Correspondence
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189917/
https://ncbi.nlm.nih.gov/pubmed/33564120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-01207-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados